Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis.

Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis.

<h4>Objectives</h4>Anti-IL-17/23 biologics are increasingly used to treat psoriasis. We aimed to elucidate characteristics of drug-induced interstitial pneumonia (DIIP) caused by anti-IL-17/23 biologics.<h4>Methods</h4>We retrospectively analyzed the clinical data of psoriasi...

Full description

Bibliographic Details
Main Authors: Hanae Miyagawa, Hiromichi Hara, Jun Araya, Shunsuke Minagawa, Takanori Numata, Yoshinori Umezawa, Akihiko Asahina, Hidemi Nakagawa, Kazuyoshi Kuwano
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0245284

Internet

https://doi.org/10.1371/journal.pone.0245284

Similar Items